Skip to main content
Fig. 2 | Annals of General Psychiatry

Fig. 2

From: Cardiometabolic comorbidities, readmission, and costs in schizophrenia and bipolar disorder: a real-world analysis

Fig. 2

Medical, pharmacy, and total costs by number of cardiometabolic comorbidities. Dollar figures reflect the costs to the hospital to deliver care in 2014 dollars. For both schizophrenia and bipolar disorder, increasing cardiometabolic comorbidity was associated with increased pharmacy, medical, and total index hospitalization costs (all p < .001). The following covariates were included in the gamma regression analyses with a log link: age, gender, race, payer, CCI, hospital region, hospital location (urban/rural), hospital type (teaching/non-teaching), and hospital bed count. * The data are presented by number of cardiometabolic comorbidities. Overall mean total cost for patients with schizophrenia was $12,781 per patient (medical and pharmacy costs of $11,771 and $1010 per patient, respectively). Overall mean total cost for patients with bipolar disorder was $9725 per patient (medical and pharmacy costs of $8878 and $847 per patient, respectively)

Back to article page